Karthik Ravishankar > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile
Kirkland & Ellis LLP Offices

1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Karthik Ravishankar

Position
Karthik Ravishankar is a partner in the Washington, D.C., office of Kirkland & Ellis LLP. He has significant experience facilitating cases through discovery and bringing cases to trial, particularly at the U.S. International Trade Commission, where he has worked on over a dozen investigations. His practice is focused on patent litigation, and he has represented clients at the ITC and in district court involving a variety of technologies, including cellular devices, mobile payments, data encryption, spray guns, and non-invasive body-contouring. Karthik’s practice also includes consulting on and litigating global FRAND issues and IP-adjacent antitrust matters.
Lawyer Rankings
United States > Intellectual property > Patents: litigation (International Trade Commission)
With extensive experience in Section 337 actions, Kirkland & Ellis LLP represents both claimants and respondents before the ITC in matters relating to a wide range of products and technologies. In Washington DC, Paul Brinkman is an ITC specialist with a long track record of litigating Section 337 cases, and Gregg LoCascio is capable of acting on a broad range of IP matters. Also in DC, Edward Donovan focuses on tech-related litigation, Karthik Ravishankar has broad experience with ITC investigations related to a variety of technologies, and Christopher Mizzo is an IP disputes expert. The group also Gregory Arovas in New York, who frequently represents tech clients at the ITC, New York-based Todd Friedman, who is a seasoned litigator, and Chicago-based patent infringement expert Jay Emerick.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism